Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease. (Q47889532)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 July 2013

Language	Label	Description	Also known as
English	Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease.	scientific article published on 31 July 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

autosomal dominant polycystic kidney disease

0 references

1 reference

based on heuristic

inferred from title

autosomal dominant polycystic kidney

1 reference

based on heuristic

inferred from title

author name string

Wendy E Boertien

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Esther Meijer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Stephan J L Bakker

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Frank S Czerwiec

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Joachim Struck

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Susan E Shoaf

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Holly B Krasa

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Ron T Gansevoort

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

0 references

publication date

31 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Kidney International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

84

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1278-1286

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23903369%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolvaptan inhibits ERK-dependent cell proliferation, Cl−secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Copeptin: clinical use of a new biomarker

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal microvascular effects of vasopressin and vasopressin antagonists

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of AVP.V1-receptor antagonist on urinary albumin excretion and renal hemodynamics in NIDDM nephropathy: role of AVP.V1-receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of vasopressin on renal hemodynamics in conscious Brattleboro rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Absolute bioavailability of tolvaptan and determination of minimally effective concentrations in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non‐peptide AVP antagonist in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics, pharmacodynamics, and safety of tolvaptan, a nonpeptide AVP antagonist, during ascending single-dose studies in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Simplified calculation of body-surface area.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Glomerular filtration rate measurements by 125I-iothalamate should be corrected for inaccurate urine collections with 131I-hippuran

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

A new equation to estimate glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating glomerular filtration rate from serum creatinine and cystatin C.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47889532&oldid=2260428865"